- Home
- FSCO vs BLFS Comparison
FSCO vs BLFS Comparison
Compare FSCO & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSCO
- BLFS
- Stock Information
- Founded
- FSCO 2013
- BLFS 1987
- Country
- FSCO United States
- BLFS United States
- Employees
- FSCO N/A
- BLFS N/A
- Industry
- FSCO Trusts Except Educational Religious and Charitable
- BLFS Medical/Dental Instruments
- Sector
- FSCO Finance
- BLFS Health Care
- Exchange
- FSCO Nasdaq
- BLFS Nasdaq
- Market Cap
- FSCO 1.3B
- BLFS 1.2B
- IPO Year
- FSCO N/A
- BLFS 1989
- Fundamental
- Price
- FSCO $7.09
- BLFS $23.29
- Analyst Decision
- FSCO
- BLFS Strong Buy
- Analyst Count
- FSCO 0
- BLFS 7
- Target Price
- FSCO N/A
- BLFS $30.57
- AVG Volume (30 Days)
- FSCO 709.7K
- BLFS 573.8K
- Earning Date
- FSCO 01-01-0001
- BLFS 05-08-2025
- Dividend Yield
- FSCO 11.44%
- BLFS N/A
- EPS Growth
- FSCO N/A
- BLFS N/A
- EPS
- FSCO N/A
- BLFS N/A
- Revenue
- FSCO N/A
- BLFS $87,762,000.00
- Revenue This Year
- FSCO N/A
- BLFS $20.32
- Revenue Next Year
- FSCO N/A
- BLFS $19.98
- P/E Ratio
- FSCO N/A
- BLFS N/A
- Revenue Growth
- FSCO N/A
- BLFS N/A
- 52 Week Low
- FSCO $4.08
- BLFS $17.15
- 52 Week High
- FSCO $6.00
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- FSCO 60.81
- BLFS 49.30
- Support Level
- FSCO $6.91
- BLFS $21.13
- Resistance Level
- FSCO $7.21
- BLFS $25.60
- Average True Range (ATR)
- FSCO 0.12
- BLFS 1.58
- MACD
- FSCO 0.05
- BLFS -0.07
- Stochastic Oscillator
- FSCO 83.29
- BLFS 48.32
About FSCO FS Credit Opportunities Corp.
FS Credit Opportunities Corp is a closed-end management investment company. The Fund's primary investment objective is to generate an attractive total return consisting of a high level of current income and capital appreciation, with a secondary objective of capital preservation. It predominantly invests in a portfolio of secured and unsecured floating and fixed-rate loans, bonds, and other types of credit instruments. The credit instruments in which it invests typically are rated below investment grade by rating agencies or would be rated below investment grade if rated. To achieve its investment objectives, the fund focuses on strategies such as Opportunistic Credit, Special Situations, and Capital Structure Solutions.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.